Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relative cost of multidrug-resistant TB medicines in Europe.
Günther G, Guglielmetti L, Leu C, van Leth F, Lange C. Günther G, et al. Among authors: van leth f. Int J Tuberc Lung Dis. 2023 May 1;27(5):341-344. doi: 10.5588/ijtld.23.0026. Int J Tuberc Lung Dis. 2023. PMID: 37143231 No abstract available.
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks. Domínguez J, et al. Among authors: van leth f. Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28. Lancet Infect Dis. 2023. PMID: 36868253 Review.
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.
Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, Diel R, Dominguez J, Floyd S, Gupta A, Huerga H, Jones-López EC, Kinikar A, Lange C, van Leth F, Liu Q, Lu W, Lu P, Rueda IL, Martinez L, Mbandi SK, Muñoz L, Padilla ES, Paradkar M, Scriba T, Sester M, Shanaube K, Sharma SK, Sloot R, Sotgiu G, Thiruvengadam K, Vashishtha R, Abubakar I, Rangaka MX. Hamada Y, et al. Among authors: van leth f. EClinicalMedicine. 2023 Jan 5;56:101815. doi: 10.1016/j.eclinm.2022.101815. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36636295 Free PMC article.
Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys.
Emery JC, Dodd PJ, Banu S, Frascella B, Garden FL, Horton KC, Hossain S, Law I, van Leth F, Marks GB, Nguyen HB, Nguyen HV, Onozaki I, Quelapio MID, Richards AS, Shaikh N, Tiemersma EW, White RG, Zaman K, Cobelens F, Houben RMGJ. Emery JC, et al. Among authors: van leth f. Elife. 2023 Dec 18;12:e82469. doi: 10.7554/eLife.82469. Elife. 2023. PMID: 38109277 Free PMC article. Review.
Reasons for using traditional and complementary care by people living with HIV on antiretroviral therapy and association with interrupted care: a mixed methods study in Eswatini.
Molemans M, Reis R, Shabalala F, Dlamini N, Masilela N, Simelane N, Pell C, Chao A, Spiegelman D, Vernooij E, van Leth F. Molemans M, et al. Among authors: van leth f. BMC Complement Med Ther. 2023 Oct 4;23(1):350. doi: 10.1186/s12906-023-04184-5. BMC Complement Med Ther. 2023. PMID: 37794359 Free PMC article.
Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.
Gatechompol S, Kerr SJ, Cardoso SW, Samaneka W, Tripathy S, Godbole S, Ghate M, Kanyama C, Nyirenda M, Sugandhavesa P, Machado A, Van Leth F, Campbell TB, Swindlells S, Avihingsanon A, Cobelens F. Gatechompol S, et al. Among authors: van leth f. AIDS. 2024 Jan 1;38(1):31-38. doi: 10.1097/QAD.0000000000003713. Epub 2023 Sep 8. AIDS. 2024. PMID: 37696248
Strengthening primary care for diabetes and hypertension in Eswatini: study protocol for a nationwide cluster-randomized controlled trial.
Theilmann M, Ginindza N, Myeni J, Dlamini S, Cindzi BT, Dlamini D, Dlamini TL, Greve M, Harkare HV, Hleta M, Khumalo P, Kolbe LM, Lewin S, Marowa LR, Masuku S, Mavuso D, Molemans M, Ntshalintshali N, Nxumalo N, Osetinsky B, Pell C, Reis R, Shabalala F, Simelane BR, Stehr L, Tediosi F, van Leth F, De Neve JW, Bärnighausen T, Geldsetzer P. Theilmann M, et al. Among authors: van leth f. Trials. 2023 Mar 22;24(1):210. doi: 10.1186/s13063-023-07096-4. Trials. 2023. PMID: 36949485 Free PMC article.
153 results